Skip to main content
. 2022 Jan 12;12:20. doi: 10.1038/s41398-021-01775-z

Fig. 2. Regional differences in Mu-opioid receptor binding between individuals at high and low opioid misuse risk.

Fig. 2

A Significant differences in baseline MOR BPND between groups was obtained in the right amygdala, with individuals in the high-risk for opioid misuse group (PMQ-H) exhibited the highest mu-opioid receptor MOR BPND. B Significant relationships between opioid misuse risk scores and baseline µ-opioid BP were also observed.